A federal appeals court upheld Federal Trade Commission findings that pomegranate-juice maker Pom Wonderful made false and misleading claims its products were effective in fighting heart disease and prostate cancer.
Honda cut its profit outlook for a second consecutive quarter, the latest indication of the growing toll of two recalls—one involving exploding air bags made by Takata and the other related to the redesigned Fit subcompact.
Chevron posted its lowest quarterly profit in five years and said it would trim its ambitious spending plans and halt share buybacks as the collapse in oil prices erased billions of dollars in cash flow.
A bankruptcy judge Friday paved the way for Dendreon to auction its flagship, Provenge, to the highest bidder, a day after Valeant Pharmaceuticals set a $296 million floor price for the prostate cancer drug.
AT&T spent $18.2 billion in the latest sale of U.S. wireless licenses, easily topping other bidders and capping a yearlong spending spree that has raised concerns the telecom giant is getting stretched.